Wnt/b-Catenin and transforming growth factor-B signaling in pulmonary fibrosis: A case for antagonistic pleiotropy?

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 2, 2014, Pages 129-131

  Scheraga, Rachel G ^a   Thannickal, Victor J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; DICKKOPF 1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LRP5 PROTEIN, HUMAN; LRP5 PROTEIN, MOUSE;

CLINICAL TRIAL (TOPIC); DISEASE COURSE; EDITORIAL; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; LUNG INJURY; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; ANIMAL; FEMALE; FIBROSING ALVEOLITIS; MALE; METABOLISM; NOTE;

ANIMALS; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MALE;

EID: 84906924737     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1037ED     Document Type: Editorial

References (14)

1. Guo Y, Xiao L, Sun L, Liu F. Wnt/b-catenin signaling: a promising new target for fibrosis diseases. Physiol Res 2012;61:337-346.
2. Königshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009;119: 772-787.
3. Flozak AS, Lam AP, Russell S, Jain M, Peled ON, Sheppard KA, Beri R, Mutlu GM, Budinger GR, Gottardi CJ. b-Catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J Biol Chem 2010;285:3157-3167.
4. Henderson WR Jr, Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA, Kahn M. Inhibition of Wnt/b-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010;107:14309-14314.
5. Chilosi M, Poletti V, Zamò A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, et al. Aberrant Wnt/b-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162:1495-1502.
6. Königshoff M, Balsara N, Pfaff EM, Kramer M, Chrobak I, Seeger W, Eickelberg O. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS One 2008;3:e2142.
7. Lam AP, Herazo-Maya J, Sennello J, Flozak A, Russell S, Mutlu G, Budinger G, DasGupta R, Varga J, Kaminski N, et al. Wnt co-receptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014;190:185-195.
8. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al. Activation of canonical Wnt signalling is required for TGF-b-mediated fibrosis. Nat Commun 2012; 3:735.
9. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011;145:926-940.
10. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009;15:1077-1081.
11. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, Thannickal VJ. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med 2014;6:231ra47.
12. Thannickal VJ. Aging, antagonistic pleiotropy and fibrotic disease. Int J Biochem Cell Biol 2010;42:1398-1400.
13. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007;317:807-810.
14. Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma SF, Tseng GC, Feingold E, Juan-Guardela BM, Richards TJ, Lussier Y, et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis. Sci Transl Med 2013;5:205ra136.